Photo from Pashtoon Kasi/Twitter
Oct 23, 2023, 13:15
Pashtoon Kasi: We should drop the modified nomenclature and just agree on just dosing schema for FOLFIRINOX
Quoting Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine, on X/Twitter:
”ESMO23 Moving forward we should drop the modified nomenclature and just agree on just dosing schema for FOLFIRINOX.
More information that less is more. No more than:
5FU 2400 mg/m2.
LV 400 mg/m2.
Oxaliplatin 60 mg/m2.
Irinotecan 150 mg/m2.
DPYD/UGT1A1 is a whole another debate.”
Source: Pashtoon Kasi/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 15:25
Nov 14, 2024, 15:20
Nov 14, 2024, 14:40
Nov 14, 2024, 14:39
Nov 14, 2024, 14:28
Nov 14, 2024, 14:05